Generic Name . | Trade Name . | Form . | Concentration . | Onset, minutes . | Peak, minutes . | Duration, hours . | Cost (WAC) (29) . |
---|---|---|---|---|---|---|---|
Ultra-rapid-acting insulins | |||||||
Faster aspart | Fiasp | Analog | U-100 | 16–20 | 63 | 5–7 | $289.36/one 10-mL vial |
$558.83/five 3-mL FlexPens | |||||||
$537.47/five 3-mL Penfill cartridges | |||||||
URLi | Lyumjev | Analog | U-100 | $274.70/one 10-mL vial | |||
$530.40/five 3-mL KwikPens | |||||||
U-200 | 15–17 | 57 | 4.6–7.3 | $424.32/two 3-mL KwikPens | |||
Rapid-acting insulins | |||||||
Insulin aspart | Novolog | Analog | U-100 | 10–20 | 30–90 | 3–5 | $289.36/one 10-mL vial |
$537.45/five 3-mL Penfill cartridges | |||||||
$558.83/five 3-mL FlexPens | |||||||
Insulin glulisine | Apidra | Analog | U-100 | 10–20 | 30–90 | 3–5 | $283.95/one 10-mL vial |
$548.52/five 3-mL SoloStar pens | |||||||
Insulin lispro | Humalog | Analog | U-100 | 10–20 | 30–90 | 3–5 | $137.35/one 10-mL vial |
$265.20/five 3-mL KwikPens or KwikPen Juniors | |||||||
U-200 | 15 | 30–90 | 3–5 | $424.32/two 3-mL KwikPens | |||
Insulin lispro, biosimilar | Admelog | Analog | U-100 | 15 | 30–90 | 3–5 | $130.76/one 10-mL vial |
$39.23/one 3-mL vial | |||||||
$252.47/five 3-mL SoloStar pens | |||||||
Insulin, inhaled | Afrezza | Human | U-100 | 12 | 35–55 | 1.5–4.5 | $353.91/90 4-unit cartridges |
$707.82/90 8-unit cartridges | |||||||
$1,061.74/90 12-unit cartridges | |||||||
Short-acting insulins | |||||||
Insulin, regular | Humulin R | Human | U-100 | 30–60 | 120–240 | 5–8 | $148.70/one 10-mL vial |
$44.61/one 3-mL vial | |||||||
Novolin R | Human | U-100 | 30 | 80–120 | Up to 8 | $137.70/one 10-mL vial | |
$25/one 10-mL vial (ReliOn) (29) |
Generic Name . | Trade Name . | Form . | Concentration . | Onset, minutes . | Peak, minutes . | Duration, hours . | Cost (WAC) (29) . |
---|---|---|---|---|---|---|---|
Ultra-rapid-acting insulins | |||||||
Faster aspart | Fiasp | Analog | U-100 | 16–20 | 63 | 5–7 | $289.36/one 10-mL vial |
$558.83/five 3-mL FlexPens | |||||||
$537.47/five 3-mL Penfill cartridges | |||||||
URLi | Lyumjev | Analog | U-100 | $274.70/one 10-mL vial | |||
$530.40/five 3-mL KwikPens | |||||||
U-200 | 15–17 | 57 | 4.6–7.3 | $424.32/two 3-mL KwikPens | |||
Rapid-acting insulins | |||||||
Insulin aspart | Novolog | Analog | U-100 | 10–20 | 30–90 | 3–5 | $289.36/one 10-mL vial |
$537.45/five 3-mL Penfill cartridges | |||||||
$558.83/five 3-mL FlexPens | |||||||
Insulin glulisine | Apidra | Analog | U-100 | 10–20 | 30–90 | 3–5 | $283.95/one 10-mL vial |
$548.52/five 3-mL SoloStar pens | |||||||
Insulin lispro | Humalog | Analog | U-100 | 10–20 | 30–90 | 3–5 | $137.35/one 10-mL vial |
$265.20/five 3-mL KwikPens or KwikPen Juniors | |||||||
U-200 | 15 | 30–90 | 3–5 | $424.32/two 3-mL KwikPens | |||
Insulin lispro, biosimilar | Admelog | Analog | U-100 | 15 | 30–90 | 3–5 | $130.76/one 10-mL vial |
$39.23/one 3-mL vial | |||||||
$252.47/five 3-mL SoloStar pens | |||||||
Insulin, inhaled | Afrezza | Human | U-100 | 12 | 35–55 | 1.5–4.5 | $353.91/90 4-unit cartridges |
$707.82/90 8-unit cartridges | |||||||
$1,061.74/90 12-unit cartridges | |||||||
Short-acting insulins | |||||||
Insulin, regular | Humulin R | Human | U-100 | 30–60 | 120–240 | 5–8 | $148.70/one 10-mL vial |
$44.61/one 3-mL vial | |||||||
Novolin R | Human | U-100 | 30 | 80–120 | Up to 8 | $137.70/one 10-mL vial | |
$25/one 10-mL vial (ReliOn) (29) |
WAC, wholesale acquisition cost.